Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × 90 days × Clear all

Phase

Phase NA 23 Phase 2 15 Phase 1/2 10 Phase 1 8 Phase EARLY_PHASE1 3 Phase 3 2 Phase 4 1

Status

Recruiting 60 Not yet recruiting 30 Active not recruiting 25 Completed 22 Terminated 4 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Opioid-Related Disorders 1 Lymphoma, Follicular 1

Interventions

Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04091009 2025-12-31

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Massachusetts General Hospital

Phase 4 Withdrawn

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡